Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 527

1.

Re: Association of Screening and Treatment for Preoperative Asymptomatic Bacteriuria with Postoperative Outcomes among US Veterans.

Schaeffer EM.

J Urol. 2019 Jun 6:101097JU0000000000000370. doi: 10.1097/JU.0000000000000370. [Epub ahead of print] No abstract available.

PMID:
31169452
2.

Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.

Alshalalfa M, Nguyen PL, Beltran H, Chen WS, Davicioni E, Zhao SG, Rebbeck TR, Schaeffer EM, Lotan TL, Feng FY, Mahal BA.

Eur Urol Oncol. 2019 Jun 1. pii: S2588-9311(19)30068-9. doi: 10.1016/j.euo.2019.05.001. [Epub ahead of print]

PMID:
31164324
3.

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.

Alshalalfa M, Liu Y, Wyatt AW, Gibb EA, Tsai HK, Erho N, Lehrer J, Takhar M, Ramnarine VR, Collins CC, Den RB, Schaeffer EM, Davicioni E, Lotan TL, Bismar TA.

Int J Cancer. 2019 May 24. doi: 10.1002/ijc.32430. [Epub ahead of print]

PMID:
31125117
4.

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M 3rd, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE.

JAMA Oncol. 2019 May 23. doi: 10.1001/jamaoncol.2019.0826. [Epub ahead of print]

PMID:
31120534
5.

African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.

Echevarria MI, Awasthi S, Cheng CH, Berglund AE, Rounbehler RJ, Gerke TA, Takhar M, Davicioni E, Klein EA, Freedland SJ, Ross AE, Schaeffer EM, Den RB, Cleveland JL, Park JY, Rayford W, Yamoah K.

J Urol. 2019 Feb 15:101097JU0000000000000193. doi: 10.1097/JU.0000000000000193. [Epub ahead of print]

PMID:
31107158
6.

Prostate cancer in sexual minorities and the influence of HIV status.

Amarasekera C, Wong V, Yura E, Manjunath A, Schaeffer E, Kundu S.

Nat Rev Urol. 2019 May 17. doi: 10.1038/s41585-019-0194-2. [Epub ahead of print] Review.

PMID:
31101896
7.

Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure?

Rao A, Vapiwala N, Schaeffer EM, Ryan CJ.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:309-320. doi: 10.1200/EDBK_239041. Epub 2019 May 17.

PMID:
31099652
8.

Germline and Somatic Mutations in Prostate Cancer for the Clinician.

Cheng HH, Sokolova AO, Schaeffer EM, Small EJ, Higano CS.

J Natl Compr Canc Netw. 2019 May 1;17(5):515-521. doi: 10.6004/jnccn.2019.7307. Review.

PMID:
31085765
9.

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2019 May 1;17(5):479-505. doi: 10.6004/jnccn.2019.0023.

PMID:
31085757
10.

Re: Continuous Low-Dose Antibiotic Prophylaxis for Adults with Repeated Urinary Tract Infections (AnTIC): A Randomised, Open-Label Trial.

Schaeffer EM.

J Urol. 2019 Apr 25:101097JU0000000000000302. doi: 10.1097/JU.0000000000000302. [Epub ahead of print] No abstract available.

PMID:
31021292
11.

The Utility of Prostate Specific Antigen Density, Prostate Health Index, and Prostate Health Index Density in Predicting Positive Prostate Biopsy Outcome is Dependent on the Prostate Biopsy Methods.

Lopes Vendrami C, McCarthy RJ, Chatterjee A, Casalino D, Schaeffer EM, Catalona WJ, Miller FH.

Urology. 2019 Mar 27. pii: S0090-4295(19)30315-2. doi: 10.1016/j.urology.2019.03.018. [Epub ahead of print]

PMID:
30926382
12.

Re: Effect of a Hospital-Associated Urinary Tract Infection Reduction Policy on General Surgery Patients.

Schaeffer EM.

J Urol. 2019 Jul;202(1):11-12. doi: 10.1097/JU.0000000000000254. Epub 2019 Jun 7. No abstract available.

PMID:
30925084
13.

sp2-Iminosugar glycolipids as inhibitors of lipopolysaccharide-mediated human dendritic cell activation in vitro and of acute inflammation in mice in vivo.

Schaeffer E, Sánchez-Fernández EM, Gonçalves-Pereira R, Flacher V, Lamon D, Duval M, Fauny JD, García Fernández JM, Mueller CG, Ortiz Mellet C.

Eur J Med Chem. 2019 May 1;169:111-120. doi: 10.1016/j.ejmech.2019.02.078. Epub 2019 Mar 5.

PMID:
30870792
14.
15.

Re: The Use of Intravesical Gentamicin to Treat Recurrent Urinary Tract Infections in Lower Urinary Tract Dysfunction.

Schaeffer EM.

J Urol. 2019 Jun;201(6):1035-1036. doi: 10.1097/01.JU.0000554667.00259.a6. No abstract available.

PMID:
30865853
16.

TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer.

Kaur HB, Lu J, Guedes LB, Maldonado L, Reitz L, Barber JR, De Marzo AM, Tomlins SA, Sfanos KS, Eisenberger M, Schaeffer EM, Joshu CE, Lotan TL.

Hum Pathol. 2019 May;87:95-102. doi: 10.1016/j.humpath.2019.02.006. Epub 2019 Mar 6.

PMID:
30851334
17.

SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.

Faisal FA, Kaur HB, Tosoian JJ, Tomlins SA, Schaeffer EM, Lotan TL.

Prostate Cancer Prostatic Dis. 2019 Mar 8. doi: 10.1038/s41391-019-0139-0. [Epub ahead of print]

PMID:
30850708
18.
19.

Re: First Experience in the UK of Treating Women with Recurrent Urinary Tract Infections with the Bacterial Vaccine Uromune®.

Schaeffer EM.

J Urol. 2018 Dec;200(6):1144-1145. doi: 10.1016/j.juro.2018.09.025. No abstract available.

PMID:
30838901
20.

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.

Liu D, Takhar M, Alshalalfa M, Erho N, Shoag J, Jenkins RB, Karnes RJ, Ross AE, Schaeffer EM, Rubin MA, Trock B, Klein EA, Den RB, Tomlins SA, Spratt DE, Davicioni E, Sboner A, Barbieri CE.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00036. Epub 2018 Jul 24.

21.

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Carlo MI, Giri VN, Paller CJ, Abida W, Alumkal JJ, Beer TM, Beltran H, George DJ, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Ryan CJ, Schaeffer EM, Stadler WM, Taplin ME, Kauff ND, Vinson J, Antonarakis ES, Cheng HH.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00060. Epub 2018 Aug 16.

22.

Re: Preoperative Urine Culture is Unnecessary in Asymptomatic Men prior to Prostate Needle Biopsy.

Schaeffer EM.

J Urol. 2019 Mar;201(3):422-423. doi: 10.1097/01.JU.0000553661.93137.6c. No abstract available.

PMID:
30759635
23.

Re: Comparison of Fosfomycin against Fluoroquinolones for Transrectal Prostate Biopsy Prophylaxis: An Individual Patient-Data Meta-Analysis.

Schaeffer EM.

J Urol. 2019 May;201(5):839-840. doi: 10.1097/JU.0000000000000164. No abstract available.

PMID:
30747893
24.

Re: Correlation of Inflammatory Mediators in Prostatic Secretion with Chronic Prostatitis and Chronic Pelvic Pain Syndrome.

Schaeffer EM.

J Urol. 2019 May;201(5):840. doi: 10.1097/01.JU.0000554003.38258.e0. No abstract available.

PMID:
30747892
25.

Closed Reduction for Developmental Dysplasia of the Hip: Early-term Results From a Prospective, Multicenter Cohort.

Sankar WN, Gornitzky AL, Clarke NMP, Herrera-Soto JA, Kelley SP, Matheney T, Mulpuri K, Schaeffer EK, Upasani VV, Williams N, Price CT; International Hip Dysplasia Institute.

J Pediatr Orthop. 2019 Mar;39(3):111-118. doi: 10.1097/BPO.0000000000000895.

26.

Lapachol and synthetic derivatives: in vitro and in vivo activities against Bothrops snake venoms.

Strauch MA, Tomaz MA, Monteiro-Machado M, Cons BL, Patrão-Neto FC, Teixeira-Cruz JDM, Tavares-Henriques MDS, Nogueira-Souza PD, Gomes SLS, Costa PRR, Schaeffer E, da Silva AJM, Melo PA.

PLoS One. 2019 Jan 28;14(1):e0211229. doi: 10.1371/journal.pone.0211229. eCollection 2019.

27.

Re: Antimicrobial Resistance in Women with Urinary Tract Infection in Primary Care: No Relation with Type 2 Diabetes Mellitus.

Schaeffer EM.

J Urol. 2019 Apr;201(4):646. doi: 10.1097/JU.0000000000000100. No abstract available.

PMID:
30653000
28.

Re: Urinary Tract Infections following Radical Cystectomy and Urinary Diversion: A Review of 1133 Patients.

Schaeffer EM.

J Urol. 2019 Apr;201(4):647. doi: 10.1097/01.JU.0000553309.83315.fd. No abstract available.

PMID:
30652999
29.

Re: Does Size Matter? Measured and Modeled Effects of Suprapubic Catheter Size on Urinary Flow.

Schaeffer EM.

J Urol. 2019 Feb;201(2):209. doi: 10.1097/01.JU.0000553053.43925.fe. No abstract available.

PMID:
30634305
30.

Need for Higher Quality Evidence to Determine the Utility of Postoperative Radiography.

Teo TL, Schaeffer EK, Mulpuri K.

J Am Acad Orthop Surg Glob Res Rev. 2018 Aug 2;2(8):e026. doi: 10.5435/JAAOSGlobal-D-18-00026. eCollection 2018 Aug. No abstract available.

31.

National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer.

Weiner AB, Ko OS, Zhu A, Spratt DE, Hu JC, Schaeffer EM.

Urol Oncol. 2019 Jun;37(6):353.e1-353.e8. doi: 10.1016/j.urolonc.2018.12.022. Epub 2019 Jan 2.

PMID:
30611643
32.

Re: Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800): Is it Worthwhile?

Schaeffer EM.

J Urol. 2019 Jan;201(1):11. doi: 10.1097/01.ju.0000550113.95081.b9. No abstract available.

PMID:
30577340
33.

Re: Bacteria on Urine Microscopy is Not Associated with Systemic Infection in Patients with Obstructing Urolithiasis.

Schaeffer EM.

J Urol. 2019 Jan;201(1):10-11. doi: 10.1097/01.ju.0000550112.95081.f0. No abstract available.

PMID:
30577339
34.

Inflammatory Bowel Disease and the Risk of Prostate Cancer.

Burns JA, Weiner AB, Catalona WJ, Li EV, Schaeffer EM, Hanauer SB, Strong S, Burns J, Hussain MHA, Kundu SD.

Eur Urol. 2019 May;75(5):846-852. doi: 10.1016/j.eururo.2018.11.039. Epub 2018 Dec 4.

PMID:
30528221
35.

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.

Sundi D, Tosoian JJ, Nyame YA, Alam R, Achim M, Reichard CA, Li J, Wilkins L, Schwen Z, Han M, Davis JW, Klein EA, Schaeffer EM, Stephenson AJ, Ross AE, Chapin BF.

Cancer. 2019 Feb 1;125(3):391-397. doi: 10.1002/cncr.31833. Epub 2018 Nov 13.

PMID:
30423193
36.

AAOS Appropriate Use Criteria: The Management of Developmental Dysplasia of the Hip in Infants up to 6 Months of Age: Intended for Use by General Pediatricians and Referring Physicians.

Schaeffer E, Lubicky J, Mulpuri K.

J Am Acad Orthop Surg. 2019 Apr 15;27(8):e364-e368. doi: 10.5435/JAAOS-D-18-00500. No abstract available.

PMID:
30418272
37.

AAOS Appropriate Use Criteria: The Management of Developmental Dysplasia of the Hip in Infants up to Six Months of Age: Intended for Use by Orthopaedic Specialists.

Schaeffer E, Lubicky J, Mulpuri K.

J Am Acad Orthop Surg. 2019 Apr 15;27(8):e369-e372. doi: 10.5435/JAAOS-D-18-00499. No abstract available.

PMID:
30418271
38.

Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer.

Rimar KJ, Glaser AP, Kundu S, Schaeffer EM, Meeks J, Psutka SP.

Bladder Cancer. 2018 Oct 29;4(4):411-418. doi: 10.3233/BLC-180188.

39.

Re: Norwegian Patients and Retail Chicken Meat Share Cephalosporin-Resistant Escherichia coli and IncK/blaCMY-2 Resistance Plasmids.

Schaeffer EM.

J Urol. 2018 Sep;200(3):478-479. doi: 10.1016/j.juro.2018.05.089. Epub 2018 May 26. No abstract available.

PMID:
30412945
40.

Re: Comparison of Fosfomycin against Fluoroquinolones for Transrectal Prostate Biopsy Prophylaxis: An Individual Patient-Data Meta-Analysis.

Schaeffer EM.

J Urol. 2018 Sep;200(3):478-479. doi: 10.1016/j.juro.2018.05.090. Epub 2018 May 26. No abstract available.

PMID:
30412944
41.

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.

Berglund AE, Rounbehler RJ, Gerke T, Awasthi S, Cheng CH, Takhar M, Davicioni E, Alshalalfa M, Erho N, Klein EA, Freedland SJ, Ross AE, Schaeffer EM, Trock BJ, Den RB, Cleveland JL, Park JY, Dhillon J, Yamoah K.

Prostate Cancer Prostatic Dis. 2019 May;22(2):292-302. doi: 10.1038/s41391-018-0103-4. Epub 2018 Oct 26.

PMID:
30367117
42.

Re: Screening for Asymptomatic Bacteruria at One Month after Adult Kidney Transplantation: Clinical Factors and Implications.

Schaeffer EM.

J Urol. 2018 Nov;200(5):925. doi: 10.1016/j.juro.2018.08.028. Epub 2018 Aug 16. No abstract available.

PMID:
30360306
43.

Re: Antagonists of Growth Hormone-Releasing Hormone Inhibit Proliferation Induced by Inflammation in Prostatic Epithelial Cells.

Schaeffer EM.

J Urol. 2018 Nov;200(5):925. doi: 10.1016/j.juro.2018.08.024. Epub 2018 Aug 16. No abstract available.

PMID:
30360305
44.

The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.

Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sjöström M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, Davicioni E, Fong L, Spratt DE, Feng FY.

J Natl Cancer Inst. 2019 Mar 1;111(3):301-310. doi: 10.1093/jnci/djy141.

PMID:
30321406
45.

Mannoside Glycolipid Conjugates Display Antiviral Activity Against Ebola Virus.

Reynard O, Schaeffer E, Volchkova VA, Cimarelli A, Mueller CG, Volchkov VE.

J Infect Dis. 2018 Nov 22;218(suppl_5):S666-S671. doi: 10.1093/infdis/jiy464.

PMID:
30239745
46.

Re: Chronic Prostatitis and Comorbid Non-Urological Overlapping Pain Conditions: A Co-Twin Control Study.

Schaeffer EM.

J Urol. 2018 Oct;200(4):679. doi: 10.1016/j.juro.2018.06.049. Epub 2018 Jul 7. No abstract available.

PMID:
30227546
47.

Re: Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-Induced Hemorrhagic Cystitis.

Schaeffer EM.

J Urol. 2018 Oct;200(4):678-679. doi: 10.1016/j.juro.2018.06.048. Epub 2018 Jul 7. No abstract available.

PMID:
30227545
48.

"Real-world" Practice Makes Perfect: Ensuring the Active Component of Active Surveillance for Prostate Cancer.

Weiner AB, Schaeffer EM, Eggener SE.

Eur Urol. 2018 Dec;74(6):708-709. doi: 10.1016/j.eururo.2018.08.041. Epub 2018 Sep 14. No abstract available.

PMID:
30224197
49.

Management of Irreducible Hip Dislocations in Infants With Developmental Dysplasia of the Hip Diagnosed Below 6 Months of Age.

Aarvold A, Schaeffer EK, Kelley S, Clarke NMP, Herrera-Soto JA, Price CT, Mulpuri K; IHDI Study Group.

J Pediatr Orthop. 2019 Jan;39(1):e39-e43. doi: 10.1097/BPO.0000000000001205.

50.

Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.

Moyer CL, Phillips R, Deek MP, Radwan N, Ross AE, Antonarakis ES, Reyes D, Wright J, Terezakis SA, Song DY, DeVille C, Walsh PC, DeWeese TL, Carducci M, Schaeffer EM, Pienta KJ, Eisenberger M, Tran PT.

World J Urol. 2018 Sep 6. doi: 10.1007/s00345-018-2477-2. [Epub ahead of print]

PMID:
30191396

Supplemental Content

Loading ...
Support Center